Chemical industry – Page 41
-
ResearchSuzuki–Miyaura–hydrogenation targets 3D drugs
Researchers design a new pathway to make sp3 enriched drug molecules
-
BusinessChemical industry roundup 2017
Economic and political pressure is encouraging industry to become more specialised as certain sectors consolidate
-
BusinessPharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year
-
NewsNew EU environmental targets for organic chemical plants
Commission sets monitoring standards alongside emissions levels
-
BusinessSanofi ordered to pull dengue vaccine
Philippines wants French drugmaker to cover immunisation program costs
-
BusinessNova Chemicals expands in Canada
Company to spend over C$2 billion growing its steam cracker by 50% and building a new polyethylene facility
-
BusinessDuPont and Sumitomo link up for seed treatments
Firms will collaborate to develop and commercialise seed-applied technologies
-
BusinessBayer and J&J lose first blood thinner lawsuit
US jury fines Xarelto makers $27.8 million for downplaying drug risks
-
BusinessEU extends glyphosate licence by 5 years
Extending herbicide’s approval until December 2022 has pleased neither industry nor environmental campaigners
-
BusinessSomething fishy about eating insects
While insects as human food remain a novelty in the West, fly larvae grown on human food waste could soon become an important protein source for fish farms
-
BusinessMerck & Co and Qiagen to build UK research hubs
Almost 2000 jobs to be created at research centres in Manchester and London
-
BusinessEuropean drug regulator heads to Amsterdam
Brexit drives EMA to relocate, taking hundreds of jobs and significant expertise away from UK
-
BusinessRussia backs new research cluster
Government touts high-tech science area as Russia’s answer to Silicon Valley
-
OpinionBeyond buckets and batches
Embracing flow chemistry means leaving behind some faithful friends
-
-
BusinessTargeting rare diseases
Is working on genetic mutations that affect only a few in every thousand people risky?
-
BusinessBayer forms cancer-drug partnership with Loxo
Alliance could see Loxo net up to $1.55bn in upfront and milestone payments
-
NewsRepublican tax bill backed by industry but not science
Chemical industry says tax overhaul will be fairer, but science groups warn that it will harm research
-
FeatureStaying one step ahead of the game
Clare Sansom examines the need for agile drug development when tackling emerging viral disease outbreaks
-
BusinessChina clamps down on polluting factories
Thousands of factories face closure or sanctions as authorities exercise new powers to curb air and water pollution